Utilising available isoniazid-resistance tests in new patients

Lancet. 2024 Oct 12;404(10461):1403. doi: 10.1016/S0140-6736(24)01914-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents* / pharmacology
  • Antitubercular Agents* / therapeutic use
  • Humans
  • Isoniazid* / therapeutic use
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis* / drug effects
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Isoniazid